Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HER-2 Positive Malignant Carcinoma of Breast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05795101
What this trial is testing

TRUDI: TDXD+Durva in HER2+/Low IBC

Who this might be right for
Invasive Breast CancerInflammatory Breast Cancer Stage IIIHER2-positive Breast Cancer+2 more
Filipa Lynce, MD 63
Testing effectiveness (Phase 2)Active Not RecruitingNCT03125928
What this trial is testing

Clinical Trial of Atezolizumab With Paclitaxel, Trastuzumab, and Pertuzumab in Patients With Metastatic HER-2 Positive Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
Fox Chase Cancer Center 16
Testing effectiveness (Phase 2)Study completedNCT03417544
What this trial is testing

Atezolizumab + Pertuzumab + Trastuzumab In CNS Mets In BC

Who this might be right for
HER2-positive Metastatic Breast CancerCentral Nervous System Metastases
Nancy Lin, MD 19
Large-scale testing (Phase 3)Looking for participantsNCT06435429
What this trial is testing

A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer

Who this might be right for
Metastatic HER2-positive Breast Cancer
Jazz Pharmaceuticals 550
Testing effectiveness (Phase 2)Study completedNCT03755141
What this trial is testing

Efficacy and Safety of Trastuzumab Biosimilar (Herzuma®) Plus Treatment of Physician's Choice (TPC) in Patients With HER-2 Positive Metastatic Breast Cancer

Who this might be right for
HER2-positive Breast CancerMetastatic Breast Cancer
National Cancer Center, Korea 109
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07787338
What this trial is testing

SHR-A1811 Monotherapy or Sequential THPy as Neoadjuvant Therapy for Stage II-III HER2-Positive Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
First Affiliated Hospital of Zhejiang University 80
Large-scale testing (Phase 3)UnknownNCT00430001
What this trial is testing

Vinorelbine Plus (+) Trastuzumab vs Docetaxel Plus (+) Trastuzumab as 1 Line Treatment for HER2 Positive (+) Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Danish Breast Cancer Cooperative Group 300
Not applicableActive Not RecruitingNCT03892655
What this trial is testing

Real World Study of Biosimilar Trastuzumab in Her2 Positive Breast Cancer

Who this might be right for
Breast Cancer
Libbs Farmacêutica LTDA 170
Early research (Phase 1)UnknownNCT05692661
What this trial is testing

A Dose Escalation Study of Proton and Carbon Ion Irradiation for HER2 Positive and Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast CancerHER2-positive Breast Cancer
Shanghai Proton and Heavy Ion Center 24
Not applicableActive Not RecruitingNCT04101851
What this trial is testing

Omission of SLNB in Triple-negative and HER2-positive Breast Cancer Patients With rCR and pCR in the Breast After NAST

Who this might be right for
Breast Cancer FemaleBreast Cancer
Toralf Reimer, MD PhD 350
Testing effectiveness (Phase 2)Looking for participantsNCT07510802
What this trial is testing

Dual-Target CAR-NK Cells for Advanced Breast Cancer HER2+ TNBC

Who this might be right for
Breast Cancer (Advanced/Metastatic)HER2-positive Breast CancerTriple-negative Breast Cancer
Beijing Biotech 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT06198751
What this trial is testing

Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer

Who this might be right for
Breast Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 104
Testing effectiveness (Phase 2)Study completedNCT00967031
What this trial is testing

Lapatinib Ditosylate and Capecitabine in Treating Patients With Stage IV Breast Cancer and Brain Metastases

Who this might be right for
Breast CancerMetastatic Cancer
UNICANCER 45
Testing effectiveness (Phase 2)Study completedNCT01677455
What this trial is testing

An Open-Label Multicenter Phase 2 Window of Opportunity Study Evaluating Ganetespib in Women With Breast Cancer

Who this might be right for
Breast CancerHER-2 Positive Breast CancerTriple Negative Breast Cancer+1 more
Synta Pharmaceuticals Corp. 51
Early research (Phase 1)Looking for participantsNCT05098210
What this trial is testing

Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Locally Advanced Cutaneous Melanoma+22 more
Fred Hutchinson Cancer Center 28
Not applicableActive Not RecruitingNCT03881605
What this trial is testing

MRI Screening Versus SYMptom-directed Surveillance for Brain Metastases Among Patients with Triple Negative or HER2+ MBC

Who this might be right for
Breast NeoplasmBrain MetastasesTriple Negative Breast Cancer+1 more
Sunnybrook Health Sciences Centre 50
Testing effectiveness (Phase 2)Study completedNCT00270894
What this trial is testing

Neoadjuvant Chemotherapy + Herceptin in HER2 Positive Stage II-III Breast Cancer Patients

Who this might be right for
Breast Neoplasm
Accelerated Community Oncology Research Network 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04158856
What this trial is testing

Adjuvant Dual Anti-HER2 Therapy in Patients With Small, Node-negative, HER2-positive Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
xuexin he 60
Testing effectiveness (Phase 2)Study completedNCT00407888
What this trial is testing

Doxorubicin Hydrochloride, Cyclophosphamide, and Filgrastim Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation With or Without Trastuzumab in Treating Patients With Breast Cancer Previously Treated With Surgery

Who this might be right for
Estrogen Receptor-positive Breast CancerHER2-positive Breast CancerStage IA Breast Cancer+6 more
University of Washington 60
Not applicableActive Not RecruitingNCT06533670
What this trial is testing

TME Alteration in HER2 Positive Breast Cancer

Who this might be right for
Breast CancerHER2-positive Breast CancerChemotherapy Effect
Seoul National University Hospital 30
Next Page